ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 47 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,000 | -60.8% | 124,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $74,000 | -65.3% | 124,200 | -47.4% | 0.00% | -75.0% |
| Q3 2021 | $213,000 | -53.3% | 236,000 | -32.8% | 0.00% | -50.0% |
| Q2 2021 | $456,000 | -14.0% | 351,000 | -7.9% | 0.01% | -20.0% |
| Q1 2021 | $530,000 | +161.1% | 381,200 | +140.1% | 0.01% | +150.0% |
| Q4 2020 | $203,000 | -14.7% | 158,800 | -1.4% | 0.00% | -20.0% |
| Q3 2020 | $238,000 | -6.3% | 161,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $254,000 | +63.9% | 161,000 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $155,000 | -64.8% | 161,000 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $440,000 | +76.7% | 161,000 | +154.7% | 0.01% | +100.0% |
| Q3 2019 | $249,000 | -3.1% | 63,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $257,000 | -56.0% | 63,200 | -24.0% | 0.00% | -57.1% |
| Q1 2019 | $584,000 | +28.9% | 83,200 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $453,000 | -49.3% | 83,200 | 0.0% | 0.01% | -33.3% |
| Q3 2018 | $894,000 | -15.3% | 83,200 | +2.7% | 0.01% | -18.2% |
| Q2 2018 | $1,055,000 | +57.0% | 81,000 | +32.8% | 0.01% | +57.1% |
| Q1 2018 | $672,000 | – | 61,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
| TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
| Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
| PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
| Perceptive Advisors | 132,300 | $929,000 | 0.03% |
| Fosun International Ltd | 29,877 | $209,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |